Sign In
Buy MRK
$125.42
-2.99 (-2.33%)
At Close: Jul 01, 2026
Merck Stock, JPMorgan And Two Others Hit New Highs
02:04pm, Thursday, 02'nd Jul 2026
Merck stock is in a buy zone after hitting a new high. Fellow Dow stock JPMorgan Chase and Amphenol are both trading around entry points.
Schwab vs. Vanguard: Which Dividend ETF Is Best for Your Portfolio?
07:45am, Wednesday, 01'st Jul 2026
Portfolio concentration and sector weightings set these two popular income funds apart for investors seeking steady cash flow.
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
06:45am, Wednesday, 01'st Jul 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4.
Merck, AbbVie probed by US lawmakers over China clinical trials: report
12:35pm, Tuesday, 30'th Jun 2026
A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck and AbbVie, were involved in clinical trials
Stock Futures Quiet to End the Month, Quarter
09:08am, Tuesday, 30'th Jun 2026
Stock futures are pointed lower to end the month and quarter as AI capex concerns linger
Merck, AbbVie probed by US lawmakers over China clinical trials: report
08:19am, Tuesday, 30'th Jun 2026
A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck...
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
07:45am, Tuesday, 30'th Jun 2026
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?
Merck & Company (MRK) Price Forecast: Can Momentum Drive New Highs?
05:08pm, Monday, 29'th Jun 2026
Merck extends its bullish breakout from a pennant pattern, supported by strong volume and higher swing lows, with technical structure pointing toward continued upside potential.
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Monday, 29'th Jun 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
06:45am, Monday, 29'th Jun 2026
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Agreement to Improve Treatment Access for People Living with HIV. Agreement will help state ADAP programs provide access to IDVYNSO.
Merck (MRK) Gains As Market Dips: What You Should Know
06:45pm, Friday, 26'th Jun 2026
Merck (MRK) closed the most recent trading day at $128.66, moving +2.56% from the previous trading session.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 26'th Jun 2026
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC's ‘Final Trades'
07:32am, Friday, 26'th Jun 2026
On CNBC's “Halftime Report Final Trades,” Jim Lebenthal, partner and chief market strategist at Cerity Partners, named Qualcomm Incorporated (NASDAQ:QCOM) as his final trade.
The Big 3: JPM, DHR, MRK
01:00pm, Thursday, 25'th Jun 2026
Dan Deming talks joins today's Big 3 and highlights JPMorgan Chase (JPM) as shares touch new record highs. He sees Danaher (DHR) as a candidate for a continuing breakout, noting a similar pattern in M
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder Cancer
11:06am, Thursday, 25'th Jun 2026
Merck wins EU approval for Keytruda plus Padcev in patients with resectable muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
